検索
Mainz Biomed NV
MYNZウォッチリストに追加
0.844USD
0.0000.00%
終値 07/01, 16:00（ET）15分遅れの株価
35.06M時価総額
損失額直近12ヶ月PER
詳細情報 Mainz Biomed NV 企業名
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed NVの企業情報
企業コードMYNZ
会社名Mainz Biomed NV
上場日Nov 04, 2021
最高経営責任者「CEO」Baechler (Guido)
従業員数19
証券種類Ordinary Share
決算期末Nov 04
本社所在地Sirius Gutenberg Park
都市MAINZ
証券取引所NASDAQ OMX - NASDAQ BASIC
国Germany
郵便番号55129
電話番号496131265140
ウェブサイトhttps://www.mainzbiomed.com/
企業コードMYNZ
上場日Nov 04, 2021
最高経営責任者「CEO」Baechler (Guido)
Mainz Biomed NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
よくある質問
Mainz Biomed NVの上位5名の株主は誰ですか？
Mainz Biomed NVの上位5名の株主は以下のとおりです。Dr. Heiner Dreismann, Ph.D.
Mainz Biomed NV（MYNZ）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Mainz Biomed NVの株式を保有している機関は33社あり、保有株式の総市場価値は約1.23Mで、全体の9.84%を占めています。2025Q4と比較して、機関の持ち株は663009.00増加しています。